Status:
RECRUITING
Investigation of Differential Biology of Benign and Malignant Renal Masses Using Advanced Magnetic Resonance Imaging Techniques
Lead Sponsor:
University of Cambridge
Conditions:
Kidney Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to develop techniques for non-invasive imaging of biology in participants with benign or malignant renal masses based on the novel scanning MRI techniques, including recently ...
Eligibility Criteria
Inclusion
- Over 18 years old
- Able to and provide written informed consent to participate
- If female, postmenopausal or if women of child bearing potential (WOCBP) using a suitable contraception
- If male, using a suitable contraceptive method for the duration of the study
- Radiologically suspected or pathologically confirmed benign or malignant renal masses, as determined by standard clinical practice
- Capable of undergoing a minimum of one study visit
Exclusion
- Contraindication or inability to tolerate MRI
- Pregnant or actively breast-feeding woman
- If using an intrauterine contraceptive device (IUCD) as a method of contraception the device should be MRI safe at 3 T (researcher to confirm)
- Clinically significant cardiac, pulmonary or neurological diseases as determined by the investigators
- Laboratory abnormalities that may impact on the study results
- Any other significant medical or psychiatric history rendering the subject ineligible as deemed by the investigators
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06016075
Start Date
January 1 2023
End Date
January 1 2026
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Department of Radiology
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ